Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Khalid khalil

Khalid khalil

Security Forces Hospital Makkah Makkah

Sray aldeen Salman,wahib

Sray aldeen Salman,wahib

Shiekh khalifa speciality hospital oncology center UAE

Rym EL FATMI

Rym EL FATMI

Faculty of Medecine of Tunis University Tunis EL MANAR Tunisia

Laila M. Noya

Laila M. Noya

MD at the National University of La Plata Argentina

Riccardo Tomasello

Riccardo Tomasello

University of Palermo Palermo Italy

Neema Tiwari

Neema Tiwari

Department of Pathology Swami Vivekanand Subharti University India

Thi Vinh An Do

Thi Vinh An Do

Hematology and Blood Transfusion Center Bach Mai Institute Hanoi Vietnam

Recommended Global Hematology Webinars & Conferences

Asia Pacific & Middle East
Canada

WORLD HEMATOLOGY SUMMIT 2023

About the conference

WORLD HEMATOLOGY SUMMIT 2023 cordially invites everyone throughout the world with immense pleasure to attend the “2nd World Congress on Hematology and Genetic Blood Disorders” to be held at Zurich, Switzerland on February 21-22, 2023, working under the Theme: To Achieve the Novel Results and Modern Researches in Hematology which fuses incite keynote introductions, Oral talks, Poster introductions and Exhibitions. This is a unique platform for the haematologists, physicians, pathologists, students, researchers, scientists to explore your work. The conference gathering is extensive and grasps distinctive research practices which chiefly centre around determination, treatment and aversion in infants, children and adolescents.   

WORLD HEMATOLOGY SUMMIT 2023 is to get-together individuals in the scholarly world and society inspired by Hematology to share the most recent patterns and imperative issues pertinent to our field/branch of knowledge. The conference gathering is extensive and grasps distinctive research practices which chiefly centre around determination, treatment and aversion in Hematology, hematological oncology and pathology.

Who can attend

Hematology Summit 2023 lays a platform for the hematologist, oncology and experts both from Industry and Academia working in countless subdomains of hematology and oncology. The congress is open for all the Hematology Doctors, Specialists, hematological oncology, Researchers, Physicians, Business Analysts, Academicians, Hematology Educators, Lab Technicians, Nurses, Nutritionists and pathology.

Why to attend?

2nd World Congress on Hematology and Genetic Blood Disorders during February 21-22, 2023 at Zurich, Switzerland is a unique platform to share the knowledge on current research. The main aim of World Hematology Summit 2023 is to discuss the recent approaches/advancements and challenges faced in relevant to hematology and oncology. This is your best chance to achieve the biggest collection of members from the hematology people group. Incredibly famous speakers, the latest strategies, advancements, and the most current updates in the field of Hematology are signs of this gathering.

Benefits of Attending our Conference:                  

  • Get publication of your abstract with DOI
  • Young Scientist Award recognition certificate and memento to the winners
  • Be acquainted with the modern-day improvements and demanding situations inside your industry
  • Our conferences provide best Platform for your research through oral presentations.
  • Learn about career improvement with all the latest technologies.
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development.
  • Provide an opportunity for research interaction and established senior investigators across the globe in the field of Diabetes
  • Share the ideas with both eminent researchers and mentors.
  • It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge and increase participation
  • Great resource for learning new career skills
  • Global exposure to your research

Target Audience

  • Hematology Scientists
  • Hematology Faculty
  • Hematology Researchers
  • Medical Colleges
  • Pathologists
  • Immunologists
  • Business Entrepreneurs
  • Hematology Associations and Societies
  • Training Institutes
  • Manufacturing Medical Devices Companies

Sessions & Tracks

Track- 01: Hematology and Hematologist

Hematology also spelled as Haematology, is a branch of drug which manages the reason, conclusion, treatment and curative action of the ailments, identified with blood and for the most part influences the construction and segments of the blood. Hematologists or Hem-pathologists are the therapeutic expert who manages the blood issue and treatment in the bigger part of the nations, the hematology is the medicinal due to fame that needs an extraordinary preparing and 8-10 years of Undergrad College more thinks about it. Also, individuals with this ability are ordinarily in an appeal.

Hem-pathologists

Medical technologists

Blood centered concerns

Pathology laboratories

Hematology Congress Oncology Colloquium Blood Disorder Conclave Hematology Conversation Oncology Conclave

Track- 2: Blood Disorders

The field of hematology covers a extensive range of disorders. Some of these disorders are compassionate, means they resolve completely with therapy or don’t cause symptoms and don’t affect overall lifespan. Some are long-lasting and lifelong but again don’t affect permanently. Some examples of blood disorders are:

  1. The following categories describe blood disorders that cause a decrease in blood components or affect their function:

·         anemia – if the disorder involves red blood cells

·         leukopenia – if the disorder affects white blood cells

·         thrombocytopenia – if the disorder concerns platelets

  1. Categories of blood disorders that increase in blood components are:

·         erythrocytosis – if the disorder involves red blood cells

·         leukocytosis – if the disorder affects white blood cells

·         thrombocythemia or thrombocytosis – if the disorder concerns platelets

Hematology Meeting Oncology Forum Blood Disorder Convention Hematology Conclave Blood Disorder Colloquium

Track-3: Blood Disorders, Symptom and Treatment

Some of the more common types of blood disorders include:

  • Anemias, including iron-deficiency anemia and sickle cell disease
  • Bleeding disorders, such as hemophilia and von Willebrand’s disease
  • Clotting disorders and blood clots (thrombophilia)
  • Blood cancers, including leukemia, lymphoma and myeloma

Symptoms of blood disorders

  • Signs of red blood cell disorders include:

Depending on your particular diagnosis, treatment might include:

  • Growth factors to stimulate blood cell production
  • Steroids or other drugs to suppress your immune system
  • Chemotherapy to destroy abnormal cells
  • Transfusions to support you with healthy blood cells
  • Gene therapy to replace or deactivate a disease-causing gene or to introduce a disease-fighting gene
  • Immunotherapy to harness the power of your own immune system to fight disease

Hematology Convention | Blood Disorder Colloquium | Oncology Forum | Hematology Convocation | Blood Disorder Seminar

Track- 04: Stem Cell Therapy

Stem cells are created in the bone marrow. They grow into different types of blood cells that the patient needs, including red blood cells, white blood cells, and platelets. In a transplant, the patient's own stem cells are killed and then replaced by stem cells from the donor.

Usually, patients are given very strong doses of chemotherapy prior to receiving a stem cell transplant. However, because of the patient's condition, they have a high risk of experiencing life-threatening treatment-related side-effects. Recently, some doctors have begun to use chemotherapy that does not cause as many side-effects before patients receive a transplant. This research study adds CAMPATH 1H to a low-dose chemotherapy regimen, followed by an allogeneic stem cell transplantation. We want to see whether adding CAMPATH 1H to the transplant medications helps in treating the disease. We also want to see whether there are fewer life-threatening side-effects from the treatment. CAMPATH 1H is a drug that is still being studied. CAMPATH 1H stays active in the body for a long time after patients receive it, which means it may work longer at preventing graft-versus-host-disease (GvHD) symptoms.

Hematology Seminar | Oncology Congress | Blood Disorder Meeting | Hematology Forum | Blood Disorder Seminar

Track- 05: Hematology Oncology

Hematology-oncology states to the combined medical practice of hematology (the study of the blood’s physiology) and oncology (the study of cancer). This type of medicine diagnoses and treats carcinomatous blood disorders and cancers and manages symptoms of these diseases and resultant tumors (if present). Hematologists-oncologists can treat:

Hodgkin lymphoma

Non-Hodgkin lymphoma

Leukemia

Multiple myeloma

Iron deficiency anemia

Hemophilia

Sickle cell disease

Thalassemia

Willebrand disease

Polycythemia vera

Clotting disorders

Hematology Colloquium | Oncology Conclave | Blood Disorder Symposium | Hematology Forum | Oncology Colloquium

Track-06: Biomarkers in Hematology and Oncology

The development of digital biomarkers for non-invasive early detection, modified diagnostic and therapeutic approaches as well as the prediction of tumor behavior is the research focus of our interdisciplinary research group. Scientists from the fields of molecular biology, medicine and data science focus on identifying relevant patterns in image data and their combination with other data such as results of molecular analysis or clinical data.

Hematology Symposium | Oncology Talks | Blood Disorder Meeting | Hematology Congress | Oncology Meeting

Track- 07: Hematology Nursing

Hematology medical attendants are the specialists in taking care of the patients with blood disorder or blood infections. They know about patients' medical history and they can help the hematologist to analyse and treat the blood related illnesses. The most imperative thing is to teach the patients to deal with the illnesses magnanimously. They can recommend the prescription as they know about the state of the disorder. They plausibly spread their assistance in the transplantation of the blood as well. Hematology nursing is commonly identified with the hematology oncology.

Research patient treatments

Prescribe medication

Operate and monitor medical equipment

Request lab work

Help with blood transfusions

Assist with diagnostic testing and analysis of results

Diagnose and treat blood diseases

Dispense medication

Hematology Forum Oncology Convention | Blood Disorder Conclave | Hematology Seminar | Oncology Conversation

Track- 08: Pediatric Hematology

Pediatric Hematology is the branch of medicine which deals with the reason, diagnosis, treatment and prevention of the diseases related to blood and blood disorders. It mainly distresses the production and components of the blood of the children. A pediatric hematologist must be as qualified as a grown-up hematologists. The different conditions influence the kids like genetic legacy. Most of the time children are affected due to hereditary blood disorders like:-

Thalassemia

Pediatric anemia

Pediatric factor VII & XIII diseases

Hereditary disorders of red cells permeability

Pediatric myelodsplasia

Pediatric myelofibrosis

Hematology Convocation | Oncology Congress | Blood Disorder Seminar | Hematology Colloquium | Blood Disorder Symposium

Track- 09: Veterinary Hematology

Laboratory tests are done on animals for a variety of reasons. Screening tests, such as a complete blood count (CBC), may be done on clinically normal animals, when they are acquired to elude a financial or demonstrative commitment to a diseased animal. To examine geriatric patients for subclinical disease or to identify a condition that might make the animal an anaesthetics or surgical risk. Screening tests are often done when an ill animal is 1st examined especially, if systemic signs of illness are present and a specific diagnosis is not apparent from the history and physical examination. Tests are also done to confirm a probable diagnosis. Tests may be done to assist in the determination of the brutality of a disease to help, formulate a prognosis and to monitor the response to therapy or progression of disease.

Blood transfusions

Blood production stimulant 

Cancer treatment

Hematology Conclave | Oncology Congress | Blood Disorder Convention | Hematology Convention | Blood Disorder Colloquium

Track- 10: Clinical Hematology

The IACH (International Academy for Clinical Hematology) is founded by an international group of physicians whose were mainly focused to stimulate good clinical practice in the field of clinical hematology. Clinical hematology is committed to the diagnosis and treatment of diseases of blood and blood forming tissues. The diseases in the field of Hematology may involve: Blood cells (red blood cells, white blood cells and platelets), other blood components and the hematopoietic organs (bone marrow, lymph nodes, spleen).

Hematology Conversation Blood Disorder Talks Oncology Convocation Hematology Colloquium Blood Disorder Congress

Track- 11: Bone Marrow Transplantation

bone marrow transplant is a medical procedure performed to replace bone marrow that has been broken or destroyed by disease, infection or chemotherapy. This procedure contains transplanting blood stem cells, which travel to the bone marrow, where they produce new blood cells and promote growth of new marrow.

Bone marrow is the spongy and fatty tissue inside our bones. It creates the following parts of the blood:

red blood cells (which carry oxygen and nutrients throughout the body)

white blood cells (which fight infection)

platelets (which are responsible for the formation of clots)

Hematology Congress | Oncology Colloquium | Blood Disorder Conclave | Hematology Conversation | Oncology Conclave

Track-12: Stem Cell Therapy

Stem cells are created in the bone marrow. They grow into different types of blood cells that the patient needs, including red blood cells, white blood cells, and platelets. In a transplant, the patient's own stem cells are killed and then replaced by stem cells from the donor.

Usually, patients are given very strong doses of chemotherapy prior to receiving a stem cell transplant. However, because of the patient's condition, they have a high risk of experiencing life-threatening treatment-related side-effects. Recently, some doctors have begun to use chemotherapy that does not cause as many side-effects before patients receive a transplant. This research study adds CAMPATH 1H to a low-dose chemotherapy regimen, followed by an allogeneic stem cell transplantation. We want to see whether adding CAMPATH 1H to the transplant medications helps in treating the disease. We also want to see whether there are fewer life-threatening side-effects from the treatment. CAMPATH 1H is a drug that is still being studied. CAMPATH 1H stays active in the body for a long time after patients receive it, which means it may work longer at preventing graft-versus-host-disease (GvHD) symptoms.

Hematology Meeting | Oncology Forum | Blood Disorder Convention | Hematology Conclave | Blood Disorder Colloquium

Track- 13: Case reports and Epidemiology

A case report is usually considered a kind of circumstantial proof. Given their intrinsic method limitations, including the absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, beside case series. However, Hematology case reports do have unaffectedly helpful roles in medical research and evidence-based drugs. Specifically, they need abridged recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between administration of teratogen to mothers and malformations in their babies was suggested by the report of a specific case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases or moreover as uncommon presentations of common diseases. They can facilitate and generate study of hypotheses, as well as conceivable mechanisms of disease. Case reports might also have given a task to play in guiding the personalization of treatments in clinical follow.

Hematology Convention | Blood Disorder Colloquium | Oncology Forum | Hematology Convocation | Blood Disorder Seminar

Track- 14: Advanced Treatment And Research In Hematology

The plan of the hematology research is to prioritize the research support throughout the hematology community. The Concept of blood circulation was introduced during 1628. Several advances are been carried out in the supervision of hematology and they are significant too. From the last 50 years the path of research is in its peak and assures that we can hypothetically overcome hematologic conditions. Several advances has been carried out in the management of hematology and they are significant too. It involves several methods including stem cell research.

Vaccines

Stem cell research

Online blood marketing.

Genome therapy or gene editing

Modern techniques to treat hematologic disorders

Hematology Seminar | Oncology Congress | Blood Disorder Meeting | Hematology Forum | Blood Disorder Seminar

Track- 15: Leukemia and Blood Cancer

Leukemia is a blood cancer triggered by an growth in the number of white blood cells in body. Individual’s white blood cells, crowd out the red blood cells and platelets that body needs to be healthy. The extra white blood cells don’t work right. Blood cancers affect blood cells and bone marrow -- the spongy tissue inside the bones where blood cells are made.

Three types of blood cells:

• White blood cells fight infection as part of the immune system.

 Platelets aids blood clot.

• Red blood cells carry oxygen to tissues and organs and bring carbon dioxide to lungs so we can breathe it out.

Hematology Colloquium | Oncology Conclave | Blood Disorder Symposium | Hematology Forum | Oncology Colloquium

Track- 16: Transfusion medicine

Transfusion medicine is the branch of medicine that contains all features of the transfusion of blood and blood components including aspects related to hemovigilance. It includes subjects of blood endowment, immunohematology and other laboratory testing for transfusion-transmitted diseases. Management and monitoring of clinical transfusion practices, patient blood management, therapeutic apheresis, stem cell collections, cellular rehabilitation and coagulation. These blood components are then transported to a central location for treating like fractionation, testing and redistribution. These testing includes defines blood type and testing for infectious diseases. Whole blood is fractionated into red blood cells, platelets and plasma. Where plasma can be further refined into separate components such as albumin, clotting factor concentrates and immunoglobulin.

Hematology Symposium | Oncology Talks | Blood Disorder Meeting | Hematology Congress | Oncology Meeting

Track- 17: Cervical Cancer

Cervical cancer is a type of cancer that arises in the cells of the cervix — the lower part of the uterus that connects to the vagina. Many strains of the human papillomavirus (HPV), a sexually transmitted infection play a role in, causing most cervical cancer. When showing to HPV, the body's immune system typically prevents the virus from doing harm. In a small percentage of people, however, the virus survives for years, contributing to the process that causes some cervical cells to become cancer cells.

Hematology Forum | Oncology Convention | Blood Disorder Conclave | Hematology Seminar | Oncology Conversation

Track-18: Effect of Advanced Technologies on Blood Based Products

A blood artefact may be well-defined as a therapeutic substance that is acquired from human blood. Some of the blood products are:-Whole blood - which is rarely used in transfusion medicine. Blood components - Suspension of red blood cells, white blood cells and platelets; Plasma derivatives - Plasma proteins such as albumin, coagulation factor suspension and immunoglobulin.

Hematology Convocation | Oncology Congress | Blood Disorder Seminar | Hematology Colloquium | Blood Disorder Symposium

Track-19: Hematology Disorders

·       Anemia.

·       Aplastic Anemia.

·       Hemolytic Anemia.

·       Iron Deficiency Anemia.

·       Megaloblastic (Pernicious) Anemia.

·       Sickle Cell Disease.

·       Thalassemia. Alpha Thalassemia. Beta Thalassemia (Cooley's Anemia)

Hematology Convocation | Oncology Congress | Blood Disorder Seminar | Hematology Colloquium | Blood Disorder Symposium

Track-20:  Hematologic abnormalities

Hematologic abnormalities are the most common complications of human immunodeficiency virus (HIV) infection being more pronounced during the late stages of the disease, thereby indicating the progressive nature of the disease. Anemia is the most frequent hematologic abnormality in HIV

Hematology Convocation | Oncology Congress | Blood Disorder Seminar | Hematology Colloquium | Hemalogic Disorder Symposium

 

Benefits of Participation

Advantages of Participating at our Conference

  • The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
  • Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our conference.
  • Meet with hundreds of like-minded experts who are pioneers in World Hematology Summit 2022 and share ideas.
  • All participants in the Conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
  • A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of  Hematology and Genetic Blood Disorders at our Keynote sessions.
  •  World Hematology Summit 2023 intensive Conference schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognized professionals.
  • Best Poster Award nominations.
  • Award for Outstanding Young Researcher.
  • Group Registration Advantages.

Benefits of Participation for Speaker

  • Worldwide appreciation of the profile of Researchers.
  • Obtain credits for professional growth.
  • Explore the latest of cutting edge analysis.
  • Make long-term bonds at social and networking activities.
  • An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
  • Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of World Hematology Summit 2023.
  • We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

  • Professional Development-Improve understanding and knowledge.
  • Attendance at conferences supports rejuvenates and energizes delegates.
  • Your involvement in our conference will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
  • Opportunities for World Hematology Summit 2023 researchers and experts in the same field to meet and exchange new ideas through a Physical Conference.

Benefit of Participation for Sponsor

  • Exposure to the international environment would increase the possibility of new companies.
  • Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
  • Increase business by our conference participants through lead generation.
  • It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
  • Conferences in Hematology and Genetic Blood Disorders provide opportunities for more attention and contemplation that could help you move your company to the next stage.
  • Benchmarking main organization plans and moving it forward.
  • Get feedback from trustworthy people at our conference to your company questions and challenges.
  • On our conference banner, website and other proceedings, branding and marketing content, the advertising logo of your company.

Benefit of Association for Collaborators

  • Nobody has this massive visitor to World Hematology Summit 2023 in the world; this is the best forum to highlight society.
  • Creating long-lasting peer relationships.
  • In our conference banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
  • The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
  • Your representatives can network to update their knowledge and understanding of your organization and services with key conference delegates.
  • World Hematology Summit 2023 advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.

 

Market Analysis

Hematology Market is increasing at a faster pace with substantial growth rates over the last few years and is probable that the market will grow significantly in the forecasted period i.e. 2021 to 2027.

Blood disorders are significant health and economic burden in worldwide populations. The growing prevalence of common blood disorders such as anemia particularly among women and hemophilia has been energetic clinical advances in the hematology market. The prevalence of certain blood cancer in developed countries is also enhanced awareness for hematology testing. The Global Hematology Market report provides a complete evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape and factors that are playing a significant role in the market.

 

To Collaborate Scientific Professionals around the World

Conference Date February 21-22, 2023

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Day 1

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by